These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 15616206)

  • 1. Immunosuppressive drugs for kidney transplantation.
    Halloran PF
    N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
    [No Abstract]   [Full Text] [Related]  

  • 2. [The immunobiology of transplant rejection and its pharmacological modification].
    Köhler H; Zanker B; Strom TB
    Dtsch Med Wochenschr; 1991 Feb; 116(7):264-9. PubMed ID: 1825196
    [No Abstract]   [Full Text] [Related]  

  • 3. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
    Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
    Transplant Proc; 1993 Feb; 25(1 Pt 1):820-2. PubMed ID: 7679844
    [No Abstract]   [Full Text] [Related]  

  • 4. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
    Watson CJ; Davies HS; Metcalfe SM; Cobbold SP; Rebello PR; Collier DS; Waldmann H; Calne RY
    Transplant Proc; 1993 Feb; 25(1 Pt 1):804-6. PubMed ID: 8438491
    [No Abstract]   [Full Text] [Related]  

  • 5. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into therapy with monoclonal antibodies in allograft transplantation.
    Schena FP
    Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical application of monoclonal antibody therapies in renal transplantation.
    Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
    Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of chronic antibody mediated-rejection: a case report.
    Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
    Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
    [No Abstract]   [Full Text] [Related]  

  • 9. Bortezomib for the treatment of de novo HLA antibody-related antibody mediated rejection.
    Al Meshari K
    Clin Transpl; 2009; ():385-6. PubMed ID: 20524302
    [No Abstract]   [Full Text] [Related]  

  • 10. The potential role of therapeutic antibodies in the regulation of rejection.
    Ettenger RB; Yadin O
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):13-7. PubMed ID: 7482810
    [No Abstract]   [Full Text] [Related]  

  • 11. Review and preview of anti-T-cell antibodies.
    Helderman JH
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):8-9. PubMed ID: 7482824
    [No Abstract]   [Full Text] [Related]  

  • 12. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
    Buhaescu I; Segall L; Goldsmith D; Covic A
    J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution and future of immunosuppression in renal transplantation.
    Goral S; Helderman JH
    Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
    de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent immunologic aspects].
    Pastural M; Lang P
    Ann Urol (Paris); 2000 Oct; 34(5):330-5. PubMed ID: 11144721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with cyclosporine.
    Langone AJ; Helderman JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
    [No Abstract]   [Full Text] [Related]  

  • 17. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical role of OKT3.
    Norman DJ
    Cardiol Clin; 1990 Feb; 8(1):97-105. PubMed ID: 2407364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful living donor kidney transplantation across HLA and ABO incompatibilities.
    Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J
    Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies in renal transplantation: old and new.
    Kuypers DR; Vanrenterghem YF
    Nephrol Dial Transplant; 2004 Feb; 19(2):297-300. PubMed ID: 14736949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.